Grant Awards in April & October 2008

Preface >>
Facts and Figures >>

Principal Investigator   Project Title/Link  
1. Grant Awards in Cycle XIX and XX    
1.1 Conventional ROTRF Research Grants - Cycle XIX    
Prof. Leszek Ignatowicz
Medical College of Georgia, Augusta, USA  
Origin and Allocation of Regulatory T cells upon Graft Rejection or Acceptance 
Prof. Victor Laubach
University of Virginia, Charlottesville, USA  
Prevention of Lung Transplant Injury by Adenosine Receptor Activation 
Dr Andrew Luster
Massachusetts General Hospital, Charlestown, USA  
Chemokine-Mediated Control of Effector and Regulatory T Cells in Lung Rejection 
Prof. Anette Melk
Medizinische Hochschule Hannover, Kinderklinik, Hannover, Germany  
Overcoming Senescence Mechanisms Will Lead to Better Renal Graft Survival 
Prof. Wei-Ping Min
University of Western Ontario, London, Canada  
Prevention of Organ Injury and Rejection in Transplantation 
Prof. Andrey Sorokin
Medical College of Wisconsin, Milwaukee, USA  
Prevention of Virus-associated Nephropathy after Renal Transplantation 
1.2 Conventional ROTRF Research Grants - Cycle XX   
Dr Ignacio Anegon
INSERM U643, Nantes, France  
Analysis of Cells That Inhibit Anti-graft Immune Responses 
Dr David Russell
University of Washington, Seattle, USA  
Histocompatible Stem Cells for Transplantation 
Dr Anna Valujskikh
Cleveland Clinic, Cleveland, USA  
Alloantibody Production in Sensitized Transplant Recipients 
Dr Barbara A. Wasowska
Johns Hopkins University, Baltimore, USA  
Sialylated IgG Antibodies Inhibit Inflammation and Graft Rejection 
1.3 Clinical ROTRF Research Grants - Cycle XIX    
Prof. Annette Boehler
University Hospital, Zurich, Switzerland  
Confocal Microscopy after Lung Transplantation: Specific Findings during Rejection? 
Dr Diana Metes
University of Pittsburgh, Pittsburgh, USA  
Immune Cells for Therapy of Post-transplant Lymphoproliferative Disorders in Pediatric Transplant Patients  
1.4 Clinical ROTRF Research Grants - Cycle XX    
Dr Neal N. Iwakoshi
Emory University, Atlanta, USA  
Transplant Rejection Mediated by Antibody 
Dr David Neujahr
Emory University, Atlanta, USA  
Predictive Modeling of Outcomes in Lung Transplantation 
Dr Emmanuel Zorn
Massachusetts General Hospital, Boston, USA  
Characterization of Immune Cells Contributing to the Rejection of Transplanted Kidneys in Humans 
2. ROTRF/JDRF Joint Grant Awards - Cycle XIX and XX    
2.1 Conventional ROTRF/JDRF Joint Grant Awards - Cycle XIX    
Dr Karen Dwyer
St. Vincent’s Hospital, Melbourne, Australia  
Prolonging Pancreatic Islet Cell Survival following Transplantation 
2.2 Conventional ROTRF/JDRF Joint Grant Awards - Cycle XX    
Dr Jacques Thibodeau
University Montreal, Montreal, Canada  
New Immunological Avenues to Improve Allograft Survival 
2.3 Clinical ROTRF/JDRF Joint Grant Awards - Cycle XIX    
Mr Paul Johnson
University of Oxford, Oxford, UK  
Optimisation of Human Pancreatic Islet Isolation